|
Delayed
Nasdaq
10:10:01 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 8.020 USD | +0.75% |
|
-0.50% | -3.78% |
| 08-13 | Rockwell Medical, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | Rockwell Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 32.08M 27.64M 26.17M 23.72M 44.51M 3.07B 44.73M 311M 120M 1.56B 120M 118M 4.93B | P/E 2026 * |
-7.88x | P/E 2027 * | -38.8x |
|---|---|---|---|---|---|
| Enterprise Value | 32.08M 27.64M 26.17M 23.72M 44.51M 3.07B 44.73M 311M 120M 1.56B 120M 118M 4.93B | EV / Sales 2026 * |
0.44x | EV / Sales 2027 * | 0.41x |
| Free-Float |
85.2% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RMTI | Delayed | |
Tradegate
| RWM | Real-time | |
CBOE
| RMTI | Real-time | |
Börse Stuttgart
| RWM | Delayed | |
Deutsche Boerse AG
| RWM | Delayed |
Last Transcript: Rockwell Medical, Inc.
| 1 day | +1.07% | ||
| 1 week | -0.50% | ||
| Current month | -3.49% | ||
| 1 month | +8.23% | ||
| 3 months | +24.94% | ||
| 6 months | -16.05% | ||
| Current year | -3.78% |
| 1 week | 7.28 | 8.34 | |
| 1 month | 7.04 | 8.5 | |
| Current year | 4.88 | 12.9 | |
| 1 year | 4.88 | 17.2 | |
| 3 years | 4.88 | 51.5 | |
| 5 years | 4.88 | 73.37 | |
| 10 years | 4.88 | 987.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Strobeck
CEO | Chief Executive Officer | 73 | 2022-06-30 |
Jesse Neri
DFI | Director of Finance/CFO | 48 | 2024-12-11 |
Heather Hunter
COO | Chief Operating Officer | 47 | 2025-09-22 |
| Director | Title | Age | Since |
|---|---|---|---|
John Cooper
BRD | Director/Board Member | 67 | 2017-09-06 |
Mark Ravich
BRD | Director/Board Member | 73 | 2017-05-31 |
Robert Radie
CHM | Chairman | 73 | 2022-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 9,633 | 0.0244% | ||
| 7/1/26 | Free | Chief Financial Officer | 15,000 | 0.0380% | ||
| 7/1/26 | Free | Executive/Senior Manager | 15,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.75% | -0.50% | -51.69% | -63.04% | 32.08M | ||
| +2.21% | +1.61% | +52.63% | +93.03% | 994B | ||
| +1.18% | +0.01% | +51.71% | +64.37% | 640B | ||
| +1.37% | +4.68% | +19.67% | +69.50% | 454B | ||
| +5.01% | +1.70% | +38.10% | +38.55% | 337B | ||
| +2.09% | -8.99% | +16.92% | +25.16% | 261B | ||
| +3.41% | +0.20% | +5.71% | +11.58% | 246B | ||
| +0.22% | -3.80% | +37.84% | +44.20% | 204B | ||
| +1.55% | -6.29% | -21.11% | -58.98% | 190B | ||
| +1.03% | -0.98% | +29.02% | +87.69% | 178B | ||
| Average | +1.92% | -5.21% | +17.88% | +31.21% | 350.48B | |
| Weighted average by Cap. | +2.06% | -4.42% | +34.79% | +57.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.34M 62.33M 59.02M 53.49M 100M 6.91B 101M 701M 270M 3.52B 272M 266M 11.11B | 78.15M 67.34M 63.76M 57.79M 108M 7.47B 109M 757M 291M 3.8B 294M 287M 12B |
| Net income | -3.94M -3.39M -3.21M -2.91M -5.46M -376M -5.49M -38.15M -14.67M -191M -14.79M -14.46M -605M | -914K -787K -745K -675K -1.27M -87.27M -1.27M -8.85M -3.4M -44.4M -3.43M -3.36M -140M |
| Net Debt | - | - |
Employees
157
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-14 | US$8.020 | +0.75% | 2,523 |
| 26-09-11 | US$7.960 | -1.00% | 42,754 |
| 26-09-10 | US$8.040 | +1.07% | 36,509 |
| 26-09-09 | US$7.955 | -1.30% | 21,388 |
| 26-09-08 | US$8.060 | +0.94% | 33,184 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.960USD
Average target price
20.00USD
Spread / Average Target
+151.26%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMTI Stock
Select your edition
All financial news and data tailored to specific country editions

















